🇺🇸 FDA

Drug profile · INN

nedosiran sodium

RIVFLOZA

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

nedosiran sodium (RIVFLOZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN nedosiran sodium
Brand RIVFLOZA
Route INJECTION
Formulation SOLUTION

Frequently asked questions

What is nedosiran sodium?

nedosiran sodium (RIVFLOZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for nedosiran sodium?

RIVFLOZA is a marketed brand name for nedosiran sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of nedosiran sodium?

nedosiran sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.